{
  "url": "https://openlegislation.uk/health-service-products-provision-and-disclosure-of-information-regulations-2018/schedule-4/paragraph-1",
  "json_url": "https://openlegislation.uk/health-service-products-provision-and-disclosure-of-information-regulations-2018/schedule-4/paragraph-1.json",
  "legislation": "uksi/2018/677",
  "legislation_title": "The Health Service Products (Provision and Disclosure of Information) Regulations 2018",
  "legislation_url": "https://openlegislation.uk/health-service-products-provision-and-disclosure-of-information-regulations-2018",
  "path": "schedule/4/paragraph/1",
  "kind": "paragraph",
  "number": "1",
  "heading": null,
  "text": "(1) The bodies specified in column 1 of Table 1, being bodies appearing to the Secretary of State to represent UK producers, are prescribed for the purposes of section 264B(1)(k) of the 2006 Act.\n(2) The purpose for which a body specified in column 1 of Table 1 may use confidential or commercially sensitive information disclosed to it under section 264B(1) of the 2006 Act is the purpose prescribed in the corresponding entry in column 2 of that Table.\nTable 1\nColumn 1 – Bodies\nColumn 2 – The purpose for which information disclosed under section 264B(1) of the 2006 Act may be used\nAssociation of British Healthcare Industries;\nAssociation of Pharmaceutical Specials Manufacturers;\nBritish Association of European Pharmaceutical Distributors;\nBritish Generic Manufacturers Association;\nBritish Healthcare Trades Association;\nBritish In Vitro Diagnostics Association;\nHealthcare Distribution Association;\nNHS Pharmacy Production Committee;\nNHS Pharmaceutical Quality Assurance;\nProprietary Association of Great Britain;\nSurgical Dressings Manufacturers Association Committee;\nUrology Trade Association.\nThe purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (l).\nAssociation of Independent Multiple Pharmacies;\nCompany Chemists' Association;\nNational Pharmacy Association.\nThe purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (k).\nBioIndustry Association;\nEthical Medicines Industry Group.\nThe purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i), (l) and (m).\nAssociation of the British Pharmaceutical Industry\nThe purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i) and (k) to (m).\nBritish Medical Association;\nDispensing Doctor's Association.\nThe purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a), (c), (d), (f), (g) and (i) to (k).\nPharmaceutical Services Negotiating Committee\nThe purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(b) and (c).",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2018/677/schedule/4/paragraph/1",
    "retrieved_at": "2026-10-28T22:57:09.068085+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}